Security key
09075P105
BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (BTAI)
CUSIP: 09075P105
Q1 2022 13F Holders as of 31 Mar 2022
- Type / Class
- Equity / Common Stock, par value $0.001
- Shares outstanding
- 27,093,277
- Total 13F shares
- 13,111,117
- Share change
- -784,413
- Total reported value
- $273,902,967
- Put/Call ratio
- 126%
- Price per share
- $20.91
- Number of holders
- 93
- Value change
- -$16,331,751
- Number of buys
- 46
- Number of sells
- 37
Report period
Q1 2022
Institutions
93
Top holders
10
BTAI full security history
Newer quarter: Q2 2022
Previous quarter: Q4 2021
BioXcel Therapeutics, Inc. SEC filings
BioXcel Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09075P105
Recent filing periods:
Top shareholders of BTAI - BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BioXcel Holdings, Inc. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 25 Jun 2021 | |
| BioXcel LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 25 Jun 2021 | |
| FMR LLC |
13F
|
Company |
15%
|
4,197,048
|
$85,326,000 | — | 31 Dec 2021 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
5.6%
|
1,508,768
|
$30,673,000 | — | 31 Dec 2021 | |
| Artemis Investment Management LLP |
13F
|
Company |
5.2%
|
1,410,382
|
$28,604,000 | — | 31 Dec 2021 | |
| STATE STREET CORP |
13F
|
Company |
5%
|
1,345,096
|
$27,346,000 | — | 31 Dec 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.8%
|
1,289,654
|
$26,218,000 | — | 31 Dec 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.8%
|
1,022,331
|
$20,784,000 | — | 31 Dec 2021 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
1.5%
|
414,484
|
$8,426,000 | — | 31 Dec 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
301,297
|
$6,125,000 | — | 31 Dec 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.87%
|
234,710
|
$4,772,000 | — | 31 Dec 2021 | |
| UBS Group AG |
13F
|
Company |
0.74%
|
199,933
|
$4,064,000 | — | 31 Dec 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.71%
|
193,307
|
$3,930,000 | — | 31 Dec 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.66%
|
177,823
|
$3,615,000 | — | 31 Dec 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.52%
|
140,984
|
$2,866,000 | — | 31 Dec 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.49%
|
131,708
|
$2,678,000 | — | 31 Dec 2021 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.36%
|
98,638
|
$2,005,000 | — | 31 Dec 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.29%
|
77,552
|
$1,577,000 | — | 31 Dec 2021 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.25%
|
66,834
|
$1,358,735 | — | 31 Dec 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.22%
|
60,221
|
$1,224,000 | — | 31 Dec 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.21%
|
56,749
|
$1,154,000 | — | 31 Dec 2021 | |
| AlphaCentric Advisors LLC |
13F
|
Company |
0.18%
|
50,000
|
$1,017,000 | — | 31 Dec 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.18%
|
49,734
|
$1,011,000 | — | 31 Dec 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.18%
|
47,829
|
$972,000 | — | 31 Dec 2021 | |
| Swiss National Bank |
13F
|
Company |
0.16%
|
42,400
|
$862,000 | — | 31 Dec 2021 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
0.15%
|
40,000
|
$813,000 | — | 31 Dec 2021 | |
| DAVENPORT & Co LLC |
13F
|
Company |
0.13%
|
34,682
|
$705,000 | — | 31 Dec 2021 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.13%
|
34,502
|
$701,000 | — | 31 Dec 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.12%
|
32,852
|
$668,000 | — | 31 Dec 2021 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.12%
|
32,375
|
$658,000 | — | 31 Dec 2021 | |
| CSS LLC/IL |
13F
|
Company |
0.12%
|
31,327
|
$637,000 | — | 31 Dec 2021 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.11%
|
29,973
|
$609,000 | — | 31 Dec 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.11%
|
29,100
|
$592,000 | — | 31 Dec 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.11%
|
28,627
|
$582,000 | — | 31 Dec 2021 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.1%
|
25,851
|
$526,000 | — | 31 Dec 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.09%
|
24,642
|
$501,000 | — | 31 Dec 2021 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.09%
|
23,442
|
$476,000 | — | 31 Dec 2021 | |
| BARCLAYS PLC |
13F
|
Company |
0.08%
|
20,929
|
$426,000 | — | 31 Dec 2021 | |
| ACT CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.07%
|
20,000
|
$407,000 | — | 31 Dec 2021 | |
| Knoll Capital Management, LLC |
13F
|
Company |
0.07%
|
20,000
|
$407,000 | — | 31 Dec 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.07%
|
19,699
|
$400,000 | — | 31 Dec 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.07%
|
19,250
|
$391,000 | — | 31 Dec 2021 | |
| TOCQUEVILLE ASSET MANAGEMENT L.P. |
13F
|
Company |
0.06%
|
17,400
|
$354,000 | — | 31 Dec 2021 | |
| HITE Hedge Asset Management LLC |
13F
|
Company |
0.06%
|
16,397
|
$333,000 | — | 31 Dec 2021 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.06%
|
16,102
|
$327,000 | — | 31 Dec 2021 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.06%
|
15,100
|
$307,000 | — | 31 Dec 2021 | |
| CNA FINANCIAL CORP |
13F
|
Company |
0.05%
|
14,359
|
$292,000 | — | 31 Dec 2021 | |
| Capital Investment Advisory Services, LLC |
13F
|
Company |
0.05%
|
14,075
|
$286,000 | — | 31 Dec 2021 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.05%
|
13,706
|
$278,643 | — | 31 Dec 2021 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.05%
|
13,557
|
$276,000 | — | 31 Dec 2021 |
Institutional Holders of BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (BTAI) as of Q1 2022
As of 31 Mar 2022,
BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (BTAI) was held by
93 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,111,117 shares.
The largest 10 holders included
FMR LLC, Artemis Investment Management LLP, STATE STREET CORP, BlackRock Inc., VANGUARD GROUP INC, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, GEODE CAPITAL MANAGEMENT, LLC, Rubric Capital Management LP, MORGAN STANLEY, and BANK OF AMERICA CORP /DE/.
This page lists
93
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2022 vs Q4 2021 Across Filers
Q4 2021 holders
90
Q1 2022 holders
93
Holder diff
3
| Investor | Q4 2021 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q4 2021 Value $ | Q1 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.